ProfileGDS5822 / ILMN_1240977
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 52% 4% 31% 22% 2% 9% 20% 32% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 122.752
GSM1276600PDAC Late Ablation Control 28.94
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 113.731
GSM1276603PDAC Late Ablation 212.622
GSM1276604PDAC Late Ablation 33.62
GSM1303940PDAC Late Ablation_anti-CTLA4 199
GSM1303941PDAC Late Ablation_anti-CTLA4 210.620
GSM1303942PDAC Late Ablation_anti-CTLA4 315.632